Remove Innovation Remove Pharmaceutical Remove SWOT
article thumbnail

Market and Competitive Intelligence Solution Poised to Redefine CI/MI Paradigms

Contify

Cultural intelligence (C) From SWOT to TOWS. We are taught SWOT – but a better model is to identify the external risks first. Several leading pharmaceutical companies working with flawed assumptions were operating with serious blind-spots. How often are we surprised by a non-direct competitor launching a radical innovation?

article thumbnail

Debunking 5 Popular Expert Network Myths

Alpha Sense BI

One AlphaSense customer has saved tens of thousands of dollars by using our AI-search technology to optimize their research at various pharmaceutical companies. However, newer evolutions of the expert network can streamline access to industry experts through innovative technology.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Top Challenges in Healthcare and Pharma Market Research

Alpha Sense BI

In this industry, innovations, M&A deals, and clinical pipelines can move quickly and have lasting repercussions on the market, which is why you need to always be on top of new developments. It’s also critical that the information you are accessing is up to date and reflects current market conditions in addition to historical data.

article thumbnail

Sources of Competitive Intelligence

Alpha Sense BI

Regulatory Documents Regulatory documents are an essential source of competitive intelligence, as they provide insights into competitors innovation priorities, product pipelines and approvals, and areas of research focus. This data is highly useful for identifying potential competitive threats and opportunities.

article thumbnail

Sources of Competitive Intelligence

Alpha Sense BI

Regulatory Documents Regulatory documents are an essential source of competitive intelligence, as they provide insights into competitors innovation priorities, product pipelines and approvals, and areas of research focus. This data is highly useful for identifying potential competitive threats and opportunities.